{"id": "1358145707027406850", "creation": 1612642144.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "quoted": "1358045408304500739", "text": "\u201cA Phase I and II trial in #China showed the #vaccine could safely trigger immune response for older participants but #Sinovac cautioned that data for the protection rate among people aged 60 and above was \u2018limited\u2019.\u201d #COVID19 #compliance #Indonesia https://t.co/y5OZ33kusX", "first_save": 1634559108.199414, "hashtags": ["#CHINA", "#VACCINE", "#SINOVAC", "#COVID19", "#COMPLIANCE", "#INDONESIA"]}